0001213900-23-048193.txt : 20230612
0001213900-23-048193.hdr.sgml : 20230612
20230612164700
ACCESSION NUMBER: 0001213900-23-048193
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230608
FILED AS OF DATE: 20230612
DATE AS OF CHANGE: 20230612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Phillips Andrew John
CENTRAL INDEX KEY: 0001921956
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39630
FILM NUMBER: 231008771
MAIL ADDRESS:
STREET 1: C/O CORMORANT ASSET MANAGEMENT, LLP
STREET 2: 200 CLARENDON STREET, FL 52
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MoonLake Immunotherapeutics
CENTRAL INDEX KEY: 0001821586
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: DORFSTRASSE 29
CITY: ZUG
STATE: V8
ZIP: 6300
BUSINESS PHONE: 41 41 510 8022
MAIL ADDRESS:
STREET 1: DORFSTRASSE 29
CITY: ZUG
STATE: V8
ZIP: 6300
FORMER COMPANY:
FORMER CONFORMED NAME: Helix Acquisition Corp
DATE OF NAME CHANGE: 20200818
4
1
ownership.xml
X0407
4
2023-06-08
0
0001821586
MoonLake Immunotherapeutics
MLTX
0001921956
Phillips Andrew John
C/O MOONLAKE IMMUNOTHERAPEUTICS
DORFSTRASSE 29
ZUG
V8
6300
SWITZERLAND
1
0
0
0
0
Option to Buy
29.18
2023-06-08
4
A
0
11297
0.00
A
2033-06-08
Class A ordinary shares, par value $0.0001 per share
11297
11297
D
This option represents a right to purchase a total of 11,297 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 8, 2024 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer.
/s/ Matthias Bodenstedt, Attorney-in-fact for Andrew John Phillips
2023-06-12